Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis

Abstract

BackgroundClear cell renal cell carcinoma (ccRCC) represents the most invasive and common adult kidney neoplasm. Mounting evidence suggests that microRNAs (miRNAs) are important regulators of gene expression. But their function in tumourigenesis in this tumour type remains elusive. With the development of high throughput technologies such as microarrays and NGS, aberrant miRNA expression has been widely observed in ccRCC. Systematic and integrative analysis of multiple microRNA expression datasets may reveal potential mechanisms by which microRNAs contribute to ccRCC pathogenesis.MethodsWe collected 5 public microRNA expression datasets in ccRCC versus non-matching normal renal tissues from GEO database and published literatures. We analyzed these data sets with an integrated bioinformatics framework to identify expression signatures. The framework incorporates a novel statistic method for abnormal gene expression detection and an in-house developed predictor to assess the regulatory activity of microRNAs. We then mapped target genes of DE-miRNAs to different databases, such as GO, KEGG, GeneGo etc, for functional enrichment analysis.ResultsUsing this framework we identified a consistent panel of eleven deregulated miRNAs shared by five independent datasets that can distinguish normal kidney tissues from ccRCC. After comparison with 3 RNA-seq based microRNA profiling studies, we found that our data correlated well with the results of next generation sequencing. We also discovered 14 novel molecular pathways that are likely to play a role in the tumourigenesis of ccRCC.ConclusionsThe integrative framework described in this paper greatly improves the inter-dataset consistency of microRNA expression signatures. Consensus expression profile should be identified at pathway or network level to address the heterogeneity of cancer. The DE-miRNA signature and novel pathways identified herein could provide potential biomarkers for ccRCC that await further validation.

Identification of MicroRNAs as Potential Biomarker for Gastric Cancer by System Biological Analysis

“…We first applied LSOSS to detect differentially expressed microRNAs and genes from the RNA-seq data. LSOSS generally outperforms the t -statistics and is more competent for cancer data analysis, as our previous studies indicated [22, 37]. Then the inverse expression pattern of miRNAs and genes was predicted by the spearman correlation.…”

Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs

“…Molecularly, the tumour suppressor von Hippel-Lindau (VHL) is frequently inactivated by mutations (1), leading to increased proliferation, enhanced angiogenesis and de-differentiation of tumour cells. ccRCC pathogenesis is linked to abnormal regulation of certain microRNAs (miRNAs) (2,3). The latter are a class of ~22 nucleotide-long, single-stranded non-coding, nucleic acid molecules involved in the regulation of proliferation (4,5).…”

Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach

“…According to the statistical evidences described in our previous work, miRNAs with larger NOD and TFP values were more likely to be candidate biomarkers and represented biomarker miRNAs that had strong abilities to regulate genes independently and, meanwhile, regulate more TF genes. The application of biomarker discovery for prostate cancer [23, 25], sepsis [26], clear cell renal cell carcinoma [27], and pediatric acute myeloid leukemia [24] demonstrated its great predictive power.…”